Antibodies Responses to COVID-19 Infection in Hospitalized Patients (No-SARS)
Antibodies Responses to SARS-CoV 2 Infection (COVID-19) in Hospitalized Patients. A Prospective Observational Study
Sponsor: Dammam Medical Complex
This observational or N/A phase trial investigates Hospitalized Patients and Laboratory-confirmed SARS-CoV 2 Infection and is currently ongoing. Dammam Medical Complex leads this study, which shows 8 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Nov 2022 — Jul 2024 [monthly]
Unknown Status
Status: Not Yet Recruiting → Unknown Status
-
Jan 2022 — Nov 2022 [monthly]
Not Yet Recruiting
-
Dec 2021 — Jan 2022 [monthly]
Not Yet Recruiting
▶ Show 3 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Not Yet Recruiting
-
Nov 2020 — Jan 2021 [monthly]
Not Yet Recruiting
-
Sep 2020 — Nov 2020 [monthly]
Not Yet Recruiting
First recorded
Aug 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Dammam Medical Complex
- Imam Abdulrahman Bin Faisal University
- Institute for Research and medical consultations (IRMC)
For direct contact, visit the study record on ClinicalTrials.gov .